Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;29(10):2015-23.
doi: 10.1038/leu.2015.119. Epub 2015 May 14.

p53-dependent non-coding RNA networks in chronic lymphocytic leukemia

Affiliations

p53-dependent non-coding RNA networks in chronic lymphocytic leukemia

C J Blume et al. Leukemia. 2015 Oct.

Abstract

Mutations of the tumor suppressor p53 lead to chemotherapy resistance and a dismal prognosis in chronic lymphocytic leukemia (CLL). Whereas p53 targets are used to identify patient subgroups with impaired p53 function, a comprehensive assessment of non-coding RNA targets of p53 in CLL is missing. We exploited the impaired transcriptional activity of mutant p53 to map out p53 targets in CLL by small RNA sequencing. We describe the landscape of p53-dependent microRNA/non-coding RNA induced in response to DNA damage in CLL. Besides the key p53 target miR-34a, we identify a set of p53-dependent microRNAs (miRNAs; miR-182-5p, miR-7-5p and miR-320c/d). In addition to miRNAs, the long non-coding RNAs (lncRNAs) nuclear enriched abundant transcript 1 (NEAT1) and long intergenic non-coding RNA p21 (lincRNA-p21) are induced in response to DNA damage in the presence of functional p53 but not in CLL with p53 mutation. Induction of NEAT1 and lincRNA-p21 are closely correlated to the induction of cell death after DNA damage. We used isogenic lymphoma cell line models to prove p53 dependence of NEAT1 and lincRNA-p21. The current work describes the p53-dependent miRNome and identifies lncRNAs NEAT1 and lincRNA-p21 as novel elements of the p53-dependent DNA damage response machinery in CLL and lymphoma.

PubMed Disclaimer

References

    1. Blood. 2009 Oct 29;114(18):3872-9 - PubMed
    1. Cell. 2007 Jun 29;129(7):1401-14 - PubMed
    1. Nat Rev Cancer. 2010 Jan;10(1):37-50 - PubMed
    1. Blood. 2008 Oct 15;112(8):3322-9 - PubMed
    1. Nat Commun. 2014 Dec 19;5:5812 - PubMed

Publication types

MeSH terms